FLXN Historical Earnings image   This FLXN historical earnings page last updated 11/19/2021
FLXN Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202111/12/20210.02B
Q2 20218/4/20210.03B
Q1 20215/12/20210.02B
Q4 20203/10/20210.03B
Q3 202011/4/20200.02B
Q2 20208/5/20200.02B
Q1 20205/7/20200.02B
Q4 20193/12/20200.02B
Q3 201911/7/20190.02B
Q2 20198/6/20190.02B
Q1 20195/8/20190.01B
Q4 20182/28/20199.54M
Q3 201811/7/20186.99M
Q2 20188/7/20183.80M
Q1 20185/8/20182.19M
Q4 20173/8/2018355000
Q3 201711/6/2017NA
Q2 20178/8/2017NA
Q1 20175/4/2017NA
Q4 20163/9/2017NA
Q3 201611/7/2016NA
Q2 20168/3/2016NA
Q1 20165/12/2016NA
Q4 20153/10/2016NA
Q3 201511/9/2015NA
Q2 20158/6/2015NA
Q1 20155/7/2015NA
Q4 20143/23/2015NA
Q3 201411/13/2014NA
Q2 20148/7/2014NA
Q1 20145/8/2014NA
FY 20133/27/2014NA
FLXN Historical Earnings EPS
Data adjusted for FLXN split history

PeriodHistorical Earnings DateGAAP
Q3 202111/12/2021-0.600
Q2 20218/4/2021-0.440
Q1 20215/12/2021-0.570
Q4 20203/10/2021-0.370
Q3 202011/4/2020-0.500
Q2 20208/5/2020-0.760
Q1 20205/7/2020-0.950
Q4 20193/12/2020-0.870
Q3 201911/7/2019-1.000
Q2 20198/6/2019-0.960
Q1 20195/8/2019-1.090
Q4 20182/28/2019-1.07
Q3 201811/7/2018-1.15
Q2 20188/7/2018-1.16
Q1 20185/8/2018-1.1
Q4 20173/8/2018-1.43
Q3 201711/6/2017-1.07
Q2 20178/8/2017-0.91
Q1 20175/4/2017-0.75
Q4 20163/9/2017-0.8
Q3 201611/7/2016-0.65
Q2 20168/3/2016-0.63
Q1 20165/12/2016-0.78
Q4 20153/10/2016-0.63
Q3 201511/9/2015-0.52
Q2 20158/6/2015-0.58
Q1 20155/7/2015-0.43
Q4 20143/23/2015-0.47
Q3 201411/13/2014-0.45
Q2 20148/7/2014-0.38
Q1 20145/8/2014-0.86
FY 20133/27/2014-23.02
Quotes delayed 20 minutes

Email EnvelopeFree FLXN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Flexion Therapeutics (FLXN) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

FMTX Past Earnings
FNCH Past Earnings
FOLD Past Earnings
FONR Past Earnings
FREQ Past Earnings
FSTX Past Earnings
FULC Past Earnings
FVE Past Earnings
FWBI Past Earnings
GALT Past Earnings
What was the record high FLXN historical earnings result?
In terms of earnings or revenue, what is the best FLXN historical earnings result that Flexion Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest FLXN historical earnings result was set in Q4 2020, when Flexion Therapeutics posted results of -0.370/share. The most successful revenue quarter within our data set was Q2 2021 when Flexion Therapeutics reported revenue of 0.03B.

What was the lowest Flexion Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest FLXN has reported, and when?

✔️Accepted answer: Within our data set, the lowest FLXN historical earnings result was set in FY 2013, when Flexion Therapeutics posted results of -23.02/share. The smallest revenue quarter within our data set was Q3 2017 when Flexion Therapeutics reported revenue of NA.

On this page we presented the FLXN historical earnings date information for Flexion Therapeutics. Reviewing that FLXN Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2020, when FLXN posted gaap of -0.370/share. Meanwhile the lowest FLXN historical earnings result was in FY 2013, when FLXN posted gaap of -23.02/share. Moving to Flexion Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2021 when FLXN reported 0.03B in revenue, while the smallest revenue quarter was Q3 2017 when FLXN reported NA in revenue.

For self directed investors doing their due diligence on FLXN or any other given stock, their research can benefit from looking into all of the Flexion Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Flexion Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for FLXN. Thanks for visiting, and the next time you need to research FLXN historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.
 

FLXN Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2021, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.